Gene: Lama3 (laminin subunit alpha 3) Rattus norvegicus
Analyze
Symbol:
Lama3
Name:
laminin subunit alpha 3
CRRD ID:
628776
Description:
Predicted to have signaling receptor binding activity. Involved in cell-cell adhesion and hemidesmosome assembly. Localizes to adherens junction; hemidesmosome; and laminin-3 complex. Human ortholog(s) of this gene implicated in junctional epidermolysis bullosa; junctional epidermolysis bullosa Herlitz type; junctional epidermolysis bullosa non-Herlitz type; and lung small cell carcinoma. Orthologous to human LAMA3 (laminin subunit alpha 3); PARTICIPATES IN syndecan signaling pathway; INTERACTS WITH (+)-schisandrin B; 2,3,7,8-tetrachlorodibenzodioxine; 2,4,6-trinitrotoluene.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Also known as:
laminin 5 alpha 3; laminin subunit alpha-3; laminin, alpha 3; LOC307582; LOW QUALITY PROTEIN: laminin subunit alpha-3; similar to Laminin alpha-3 chain precursor (Nicein alpha subunit)
Orthologs:
Latest Assembly:
Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Rnor_6.0 18 3,704,866 - 3,941,215 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 18 3,705,916 - 3,940,838 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 18 3,712,673 - 3,939,550 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 18 4,030,463 - 4,121,355 (+) NCBI RGSC3.4 rn4 RGSC3.4 RGSC_v3.1 18 4,030,462 - 4,121,355 (+) NCBI Celera 18 3,569,544 - 3,806,888 (+) NCBI Celera Cytogenetic Map 18 p13 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Disease Annotations
Imported Annotations - ClinVar
idiopathic pulmonary fibrosis ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Idiopathic fibrosing alveolitis, chronic form ClinVar junctional epidermolysis bullosa ISO RGD:1345784 8554872 ClinVar Annotator: match by OMIM:226700 ClinVar junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Junctional epidermolysis bullosa gravis of Herlitz ClinVar PMID:24033266 more ... junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Junctional epidermolysis bullosa gravis of Herlitz ClinVar PMID:24033266 , PMID:25741868 junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Junctional epidermolysis bullosa gravis of Herlitz ClinVar PMID:28492532 junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Herlitz-type junctional epidermolysis bullosa ClinVar PMID:11810295 more ... junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Herlitz-type junctional epidermolysis bullosa ClinVar PMID:12915477 junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Herlitz-type junctional epidermolysis bullosa ClinVar PMID:8586427 junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Herlitz-type junctional epidermolysis bullosa ClinVar PMID:25741868 junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Herlitz-type junctional epidermolysis bullosa ClinVar PMID:26635394 junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Herlitz-type junctional epidermolysis bullosa ClinVar PMID:15373767 junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Herlitz-type junctional epidermolysis bullosa ClinVar PMID:16473856 , PMID:25525159 junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Herlitz-type junctional epidermolysis bullosa ClinVar PMID:27375110 junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Junctional epidermolysis bullosa gravis of Herlitz ClinVar PMID:7633458 more ... junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Herlitz-type junctional epidermolysis bullosa ClinVar PMID:16473856 junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Junctional epidermolysis bullosa gravis of Herlitz ClinVar PMID:12943669 , PMID:28492532 junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Junctional epidermolysis bullosa gravis of Herlitz ClinVar PMID:10366601 more ... junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Herlitz-type junctional epidermolysis bullosa ClinVar PMID:11810295 junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Herlitz-type junctional epidermolysis bullosa ClinVar PMID:22434185 junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Herlitz-type junctional epidermolysis bullosa ClinVar junctional epidermolysis bullosa non-Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: EPIDERMOLYSIS BULLOSA JUNCTIONALIS, NON-HERLITZ TYPE ClinVar PMID:25741868 , PMID:28492532 junctional epidermolysis bullosa non-Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: EPIDERMOLYSIS BULLOSA JUNCTIONALIS, NON-HERLITZ TYPE ClinVar PMID:25741868 junctional epidermolysis bullosa non-Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE ClinVar PMID:16473856 , PMID:25525159 junctional epidermolysis bullosa non-Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by term: EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE ClinVar junctional epidermolysis bullosa non-Herlitz type ISO RGD:1345784 8554872 ClinVar Annotator: match by OMIM:226650 ClinVar PMID:11810295 Laryngo Onycho Cutaneous Syndrome ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Laryngoonychocutaneous syndrome ClinVar PMID:24033266 , PMID:25741868 Laryngo Onycho Cutaneous Syndrome ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Laryngo-onycho-cutaneous syndrome ClinVar PMID:24033266 more ... Laryngo Onycho Cutaneous Syndrome ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Laryngo-onycho-cutaneous syndrome ClinVar PMID:11810295 Laryngo Onycho Cutaneous Syndrome ISO RGD:1345784 8554872 ClinVar Annotator: match by term: Laryngoonychocutaneous syndrome ClinVar PMID:28492532 Laryngo Onycho Cutaneous Syndrome ISO RGD:1345784 8554872 ClinVar Annotator: match by OMIM:245660 ClinVar PMID:25741868 Laryngo Onycho Cutaneous Syndrome ISO RGD:1345784 8554872 ClinVar Annotator: match by OMIM:245660 ClinVar Laryngo Onycho Cutaneous Syndrome ISO RGD:1345784 8554872 ClinVar Annotator: match by OMIM:245660 ClinVar PMID:12915477
Imported Annotations - CTD
chronic ulcer of skin ISO RGD:1345784 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:12915477 junctional epidermolysis bullosa ISO RGD:1345784 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:12915477 Laryngo Onycho Cutaneous Syndrome ISO RGD:1345784 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:12915477 nail disease ISO RGD:1345784 11554173 CTD Direct Evidence: marker/mechanism CTD PMID:12915477 Wounds and Injuries ISO RGD:1345784 11554173 CTD Direct Evidence: therapeutic CTD PMID:15541073 Imported Annotations - OMIM
junctional epidermolysis bullosa Herlitz type ISO RGD:1345784 7240710 OMIM junctional epidermolysis bullosa non-Herlitz type ISO RGD:1345784 7240710 OMIM Laryngo Onycho Cutaneous Syndrome ISO RGD:1345784 7240710 OMIM
(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LAMA3 mRNA] CTD PMID:31150632 1,2-dichloroethane decreases expression ISO RGD:1615178 6480464 ethylene dichloride results in decreased expression of LAMA3 mRNA CTD PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO RGD:1615178 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of LAMA3 mRNA] CTD PMID:22206623 1,2-dimethylhydrazine increases expression ISO RGD:1615178 6480464 1, 2-Dimethylhydrazine results in increased expression of LAMA3 mRNA CTD PMID:22206623 1-octadec-9-enoylglycero-3-phosphate increases expression ISO RGD:1345784 6480464 lysophosphatidic acid results in increased expression of LAMA3 mRNA CTD PMID:15541073 17beta-estradiol affects expression ISO RGD:1345784 6480464 Estradiol affects the expression of LAMA3 mRNA CTD PMID:25321415 17beta-estradiol increases expression ISO RGD:1345784 6480464 Estradiol results in increased expression of LAMA3 mRNA CTD PMID:19619570 17beta-estradiol multiple interactions ISO RGD:1345784 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LAMA3 mRNA more ... CTD PMID:17404688 more ... 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1345784 6480464 Dihydrotestosterone results in increased expression of LAMA3 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1345784 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LAMA3 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1615178 6480464 Tetrachlorodibenzodioxin affects the expression of LAMA3 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1345784 6480464 Tetrachlorodibenzodioxin results in increased expression of LAMA3 mRNA CTD PMID:12377990 , PMID:22903824 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of LAMA3 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of LAMA3 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1345784 6480464 Tetrachlorodibenzodioxin results in decreased expression of LAMA3 mRNA CTD PMID:19619570 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1615178 6480464 Trinitrobenzenesulfonic Acid results in increased expression of LAMA3 mRNA CTD PMID:17982090 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of LAMA3 mRNA CTD PMID:21346803 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of LAMA3 mRNA CTD PMID:21346803 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1345784 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LAMA3 mRNA CTD PMID:16997883 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of LAMA3 mRNA CTD PMID:19162173 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of LAMA3 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide decreases expression ISO RGD:1615178 6480464 Fenretinide results in decreased expression of LAMA3 mRNA CTD PMID:28973697 8-Br-cAMP multiple interactions ISO RGD:1345784 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LAMA3 mRNA CTD PMID:16997883 9-cis-retinoic acid decreases expression ISO RGD:1345784 6480464 Alitretinoin results in decreased expression of LAMA3 mRNA CTD PMID:15982314 adefovir pivoxil increases expression ISO RGD:1345784 6480464 adefovir dipivoxil results in increased expression of LAMA3 mRNA CTD PMID:25596134 aflatoxin B1 increases expression ISO RGD:1345784 6480464 Aflatoxin B1 results in increased expression of LAMA3 mRNA CTD PMID:21641981 aflatoxin B1 increases methylation ISO RGD:1345784 6480464 Aflatoxin B1 results in increased methylation of LAMA3 exon, Aflatoxin B1 results in increased methylation of LAMA3 intron CTD PMID:30157460 all-trans-4-oxoretinoic acid decreases expression ISO RGD:1345784 6480464 4-oxoretinoic acid results in decreased expression of LAMA3 mRNA CTD PMID:15982314 all-trans-retinoic acid decreases expression ISO RGD:1345784 6480464 Tretinoin metabolite results in decreased expression of LAMA3 mRNA, Tretinoin results in decreased expression of LAMA3 mRNA CTD PMID:15982314 all-trans-retinoic acid increases expression ISO RGD:1345784 6480464 Tretinoin results in increased expression of LAMA3 mRNA CTD PMID:23830798 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LAMA3 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of LAMA3 mRNA CTD PMID:30779732 antirheumatic drug increases expression ISO RGD:1345784 6480464 Antirheumatic Agents results in increased expression of LAMA3 mRNA CTD PMID:24449571 arsenous acid increases expression ISO RGD:1345784 6480464 Arsenic Trioxide results in increased expression of LAMA3 mRNA CTD PMID:20458559 benzo[a]pyrene increases expression ISO RGD:1345784 6480464 Benzo(a)pyrene results in increased expression of LAMA3 mRNA CTD PMID:22316170 benzo[a]pyrene decreases expression ISO RGD:1615178 6480464 Benzo(a)pyrene results in decreased expression of LAMA3 mRNA CTD PMID:32417428 benzo[a]pyrene decreases methylation ISO RGD:1345784 6480464 Benzo(a)pyrene results in decreased methylation of LAMA3 exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1345784 6480464 Benzo(a)pyrene affects the methylation of LAMA3 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1615178 6480464 Benzo(a)pyrene results in increased expression of LAMA3 mRNA CTD PMID:22610609 benzo[b]fluoranthene increases expression ISO RGD:1615178 6480464 benzo(b)fluoranthene results in increased expression of LAMA3 mRNA CTD PMID:26377693 benzo[e]pyrene increases methylation ISO RGD:1345784 6480464 benzo(e)pyrene results in increased methylation of LAMA3 intron CTD PMID:30157460 benzo[e]pyrene affects methylation ISO RGD:1345784 6480464 benzo(e)pyrene affects the methylation of LAMA3 exon CTD PMID:30157460 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:1345784 6480464 Mustard Gas results in increased degradation of [LAMA3 protein binds to LAMB3 protein binds to LAMC2 protein] CTD PMID:18095945 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LAMA3 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A increases expression ISO RGD:1345784 6480464 bisphenol A results in increased expression of LAMA3 mRNA CTD PMID:27685785 bisphenol F increases expression ISO RGD:1615178 6480464 bisphenol F results in increased expression of LAMA3 mRNA CTD PMID:30951980 butan-1-ol multiple interactions ISO RGD:1345784 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of LAMA3 mRNA CTD PMID:29432896 butanal decreases expression ISO RGD:1345784 6480464 butyraldehyde results in decreased expression of LAMA3 mRNA CTD PMID:26079696 cadmium dichloride affects expression ISO RGD:1345784 6480464 Cadmium Chloride affects the expression of LAMA3 mRNA CTD PMID:25596134 calcitriol increases expression ISO RGD:1345784 6480464 Calcitriol results in increased expression of LAMA3 mRNA CTD PMID:26485663 calcitriol decreases expression ISO RGD:1345784 6480464 Calcitriol results in decreased expression of LAMA3 mRNA CTD PMID:26485663 carbon nanotube affects expression ISO RGD:1615178 6480464 Nanotubes, Carbon affects the expression of LAMA3 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1615178 6480464 Nanotubes, Carbon analog results in decreased expression of LAMA3 mRNA CTD PMID:25554681 chloroacetaldehyde affects expression ISO RGD:1345784 6480464 chloroacetaldehyde affects the expression of LAMA3 mRNA CTD PMID:25596134 chloropicrin affects expression ISO RGD:1345784 6480464 chloropicrin affects the expression of LAMA3 mRNA CTD PMID:26352163 chloropicrin decreases expression ISO RGD:1345784 6480464 chloropicrin results in decreased expression of LAMA3 mRNA CTD PMID:28476498 cidofovir anhydrous affects expression ISO RGD:1345784 6480464 Cidofovir affects the expression of LAMA3 mRNA CTD PMID:25596134 cisplatin increases expression ISO RGD:1345784 6480464 Cisplatin results in increased expression of LAMA3 mRNA CTD PMID:25596134 cisplatin decreases expression ISO RGD:1345784 6480464 Cisplatin results in decreased expression of LAMA3 mRNA CTD PMID:27392435 clodronic acid increases expression ISO RGD:1345784 6480464 Clodronic Acid results in increased expression of LAMA3 mRNA CTD PMID:25596134 cyclosporin A decreases expression ISO RGD:1345784 6480464 Cyclosporine results in decreased expression of LAMA3 mRNA CTD PMID:20106945 cyclosporin A affects expression ISO RGD:1345784 6480464 Cyclosporine affects the expression of LAMA3 mRNA CTD PMID:25596134 dexamethasone multiple interactions ISO RGD:1345784 6480464 [Dexamethasone co-treated with 8-Bromo Cyclic Adenosine Monophosphate co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of LAMA3 mRNA CTD PMID:16997883 diarsenic trioxide increases expression ISO RGD:1345784 6480464 Arsenic Trioxide results in increased expression of LAMA3 mRNA CTD PMID:20458559 dibutyl phthalate decreases expression ISO RGD:1615178 6480464 Dibutyl Phthalate results in decreased expression of LAMA3 mRNA CTD PMID:17361019 , PMID:21266533 dichloroacetic acid decreases expression ISO RGD:1615178 6480464 Dichloroacetic Acid results in decreased expression of LAMA3 mRNA CTD PMID:28962523 dioxygen increases expression ISO RGD:1345784 6480464 Oxygen deficiency results in increased expression of LAMA3 mRNA CTD PMID:25596134 dioxygen multiple interactions ISO RGD:1615178 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LAMA3 mRNA CTD PMID:30529165 doxorubicin decreases expression ISO RGD:1615178 6480464 Doxorubicin results in decreased expression of LAMA3 mRNA CTD PMID:15033991 endosulfan increases expression ISO RGD:1345784 6480464 Endosulfan results in increased expression of LAMA3 mRNA CTD PMID:26615145 endosulfan affects expression EXP 6480464 Endosulfan affects the expression of LAMA3 mRNA CTD PMID:29391264 ethanol increases expression ISO RGD:1615178 6480464 Ethanol results in increased expression of LAMA3 mRNA CTD PMID:30319688 folic acid decreases expression ISO RGD:1615178 6480464 Folic Acid results in decreased expression of LAMA3 mRNA CTD PMID:25629700 folic acid multiple interactions ISO RGD:1615178 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of LAMA3 mRNA] CTD PMID:22206623 formaldehyde decreases expression ISO RGD:1345784 6480464 Formaldehyde results in decreased expression of LAMA3 mRNA CTD PMID:20655997 formaldehyde increases expression ISO RGD:1345784 6480464 Formaldehyde results in increased expression of LAMA3 mRNA CTD PMID:27905399 ibuprofen decreases expression ISO RGD:1345784 6480464 Ibuprofen results in decreased expression of LAMA3 mRNA CTD PMID:25596134 ifosfamide increases expression ISO RGD:1345784 6480464 Ifosfamide results in increased expression of LAMA3 mRNA CTD PMID:25596134 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LAMA3 mRNA CTD PMID:22129741 isotretinoin decreases expression ISO RGD:1345784 6480464 Isotretinoin results in decreased expression of LAMA3 mRNA CTD PMID:15982314 lead diacetate affects expression EXP 6480464 lead acetate affects the expression of LAMA3 mRNA CTD PMID:21864555 lead diacetate decreases expression ISO RGD:1615178 6480464 lead acetate results in decreased expression of LAMA3 mRNA CTD PMID:22609695 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of LAMA3 mRNA CTD PMID:24136188 lysophosphatidylcholine increases expression ISO RGD:1345784 6480464 Lysophosphatidylcholines results in increased expression of LAMA3 mRNA CTD PMID:15541073 mercury dichloride decreases expression EXP 6480464 Mercuric Chloride results in decreased expression of LAMA3 mRNA CTD PMID:16507785 methapyrilene increases methylation ISO RGD:1345784 6480464 Methapyrilene results in increased methylation of LAMA3 intron CTD PMID:30157460 methapyrilene affects methylation ISO RGD:1345784 6480464 Methapyrilene affects the methylation of LAMA3 exon CTD PMID:30157460 methylphenidate decreases expression ISO RGD:1615178 6480464 Methylphenidate results in decreased expression of LAMA3 mRNA CTD PMID:22470460 mifepristone decreases expression ISO RGD:1345784 6480464 Mifepristone results in decreased expression of LAMA3 mRNA CTD PMID:17584828 ML-7 affects localization ISO RGD:1345784 6480464 ML 7 affects the localization of LAMA3 protein CTD PMID:14691950 N-nitrosodiethylamine increases expression ISO RGD:1345784 6480464 Diethylnitrosamine results in increased expression of LAMA3 mRNA CTD PMID:21527772 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of LAMA3 mRNA CTD PMID:22129741 N-nitrosodiethylamine decreases expression ISO RGD:1615178 6480464 Diethylnitrosamine results in decreased expression of LAMA3 mRNA CTD PMID:24535843 N-nitrosodiethylamine multiple interactions ISO RGD:1615178 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of LAMA3 mRNA CTD PMID:24535843 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of LAMA3 mRNA CTD PMID:24136188 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of LAMA3 mRNA CTD PMID:17483316 , PMID:18417182 palbociclib increases expression ISO RGD:1345784 6480464 palbociclib results in increased expression of LAMA3 mRNA CTD PMID:22869556 phenobarbital multiple interactions ISO RGD:1615178 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of LAMA3 mRNA CTD PMID:24535843 phenobarbital decreases expression ISO RGD:1615178 6480464 Phenobarbital results in decreased expression of LAMA3 mRNA CTD PMID:23091169 pirinixic acid multiple interactions ISO RGD:1615178 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of LAMA3 mRNA] CTD PMID:20059764 pirinixic acid decreases expression ISO RGD:1615178 6480464 pirinixic acid results in decreased expression of LAMA3 mRNA CTD PMID:17426115 more ... potassium dichromate decreases expression ISO RGD:1615178 6480464 Potassium Dichromate results in decreased expression of LAMA3 mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of LAMA3 mRNA CTD PMID:19162173 progesterone multiple interactions ISO RGD:1345784 6480464 [Progesterone co-treated with Estradiol] results in decreased expression of LAMA3 mRNA CTD PMID:17404688 silicon dioxide increases expression ISO RGD:1345784 6480464 Silicon Dioxide analog results in increased expression of LAMA3 mRNA CTD PMID:25895662 sodium arsenite affects methylation ISO RGD:1345784 6480464 sodium arsenite affects the methylation of LAMA3 gene CTD PMID:28589171 sphingosine 1-phosphate increases expression ISO RGD:1345784 6480464 sphingosine 1-phosphate results in increased expression of LAMA3 mRNA CTD PMID:15541073 sulforaphane decreases expression ISO RGD:1615178 6480464 sulforafan results in decreased expression of LAMA3 mRNA CTD PMID:30529165 sunitinib increases expression ISO RGD:1345784 6480464 Sunitinib results in increased expression of LAMA3 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1615178 6480464 Tamoxifen affects the expression of LAMA3 mRNA CTD PMID:20937368 testosterone increases expression ISO RGD:1615178 6480464 Testosterone results in increased expression of LAMA3 mRNA CTD PMID:20844152 tetrachloroethene decreases expression ISO RGD:1615178 6480464 Tetrachloroethylene results in decreased expression of LAMA3 mRNA CTD PMID:28973375 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of LAMA3 mRNA CTD PMID:16644059 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of LAMA3 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of LAMA3 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:1615178 6480464 Carbon Tetrachloride results in decreased expression of LAMA3 mRNA CTD PMID:27339419 , PMID:31919559 titanium dioxide increases expression ISO RGD:1615178 6480464 titanium dioxide results in increased expression of LAMA3 mRNA CTD PMID:23409001 trichloroethene decreases expression ISO RGD:1615178 6480464 Trichloroethylene results in decreased expression of LAMA3 mRNA CTD PMID:25549359 trimellitic anhydride decreases expression ISO RGD:1615178 6480464 trimellitic anhydride results in decreased expression of LAMA3 mRNA CTD PMID:19042947 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of LAMA3 mRNA CTD PMID:30589522 troglitazone decreases expression ISO RGD:1615178 6480464 troglitazone results in decreased expression of LAMA3 mRNA CTD PMID:28973697 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of LAMA3 mRNA CTD PMID:24136188 valproic acid increases expression ISO RGD:1345784 6480464 Valproic Acid results in increased expression of LAMA3 mRNA CTD PMID:23179753 Y-27632 affects localization ISO RGD:1345784 6480464 Y 27632 affects the localization of LAMA3 protein CTD PMID:14691950 zoledronic acid increases expression ISO RGD:1345784 6480464 zoledronic acid results in increased expression of LAMA3 mRNA CTD PMID:20977926 more ...
Gene-Chemical Interaction Annotations
